[HTML][HTML] Investigating the competition between ACE2 natural molecular interactors and SARS-CoV-2 candidate inhibitors
The SARS-CoV-2 pandemic still poses a threat to the global health as the virus continues
spreading in most countries. Therefore, the identification of molecules capable of inhibiting …
spreading in most countries. Therefore, the identification of molecules capable of inhibiting …
[HTML][HTML] DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic
A Villa, E Brunialti, J Dellavedova, C Meda… - Pharmacological …, 2022 - Elsevier
All the different coronavirus SARS-CoV-2 variants isolated so far share the same
mechanism of infection mediated by the interaction of their spike (S) glycoprotein with …
mechanism of infection mediated by the interaction of their spike (S) glycoprotein with …
[HTML][HTML] DNA aptamers block the receptor binding domain at the spike protein of SARS-CoV-2
DNA aptamers are versatile molecular species obtained by the folding of short single-
stranded nucleotide sequences, with highly specific recognition capabilities against …
stranded nucleotide sequences, with highly specific recognition capabilities against …
Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2
CG Benítez-Cardoza, JL Vique-Sánchez - Computers in Biology and …, 2021 - Elsevier
We investigated compounds selected by molecular docking to identify a specific treatment
for COVID-19 that decreases the interaction between angiotensin-converting enzyme 2 …
for COVID-19 that decreases the interaction between angiotensin-converting enzyme 2 …
[HTML][HTML] Repurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
Respiratory transmission is the primary route of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection. Angiotensin I converting enzyme 2 (ACE2) is the …
Coronavirus 2 (SARS-CoV-2) infection. Angiotensin I converting enzyme 2 (ACE2) is the …
A universal DNA aptamer as an efficient inhibitor against spike-protein/hACE2 interactions
A universal aptamer against spike-proteins of diverse SARS-CoV-2 variants was discovered
via DNA SELEX towards the wild-type (WT) spike-protein. This aptamer, A1C1, binds to the …
via DNA SELEX towards the wild-type (WT) spike-protein. This aptamer, A1C1, binds to the …
Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
There is increasing evidence that ACE2 gene polymorphism can modulate the interaction
between ACE2 and the SARS-CoV-2 spike protein affecting the viral entry into the host cell …
between ACE2 and the SARS-CoV-2 spike protein affecting the viral entry into the host cell …
Potential inhibitors of the interaction between ACE2 and SARS-CoV-2 (RBD), to develop a drug
CG Benitez-Cardoza, JL Vique-Sanchez - Life sciences, 2020 - Elsevier
Aims The COVID-19 disease caused by the SARS-CoV-2 has become a pandemic and
there are no effective treatments that reduce the contagion. It is urgent to propose new …
there are no effective treatments that reduce the contagion. It is urgent to propose new …
Repurposing of Approved Drugs with Potential to Interact with SARS-CoV-2 Receptor
A Sajib - 2020 - preprints.org
Respiratory transmission is the primary route of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection. Angiotensin I converting enzyme 2 (ACE2) is the …
Coronavirus 2 (SARS-CoV-2) infection. Angiotensin I converting enzyme 2 (ACE2) is the …
[HTML][HTML] The repurposed ACE2 inhibitors: SARS-CoV-2 entry blockers of Covid-19
The highly infectious disease COVID-19 is induced by SARS-coronavirus 2 (SARS-CoV-2),
which has spread rapidly around the globe and was announced as a pandemic by the World …
which has spread rapidly around the globe and was announced as a pandemic by the World …
相关搜索
- sars cov dna aptamers
- sars cov spike protein
- sars cov approved drugs
- sars cov ace2 inhibitors
- sars cov entry blockers
- ace2 inhibitors entry blockers
- sars cov identifying compounds
- sars cov docking simulation
- sars cov peptide ligands
- sars cov covid 19
- ace2 inhibitors covid 19
- sars cov candidate inhibitors
- sars cov ace2 polymorphisms
- sars cov human ace2